Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Alkem Laboratories Limited

Market Cap 633B 6.66B 5.76B 5.3B 4.97B 9.32B 9.46B 62.86B 24.41B 308B 24.99B 24.46B 1,068B P/E Ratio 2026
27.5x
P/E Ratio 2027 * 27x
Enterprise Value 605B 6.36B 5.5B 5.07B 4.75B 8.91B 9.04B 60.07B 23.33B 294B 23.88B 23.38B 1,020B EV / Sales 2026
4.3x
EV / Sales 2027 * 3.64x
Free-Float
37.09%
Yield 2026
1%
Yield 2027 * 0.97%
1 day-0.07%
1 week+0.89%
Current month-3.64%
1 month-3.01%
3 months-1.07%
6 months-5.91%
Current year-3.79%
1 week 5,175.5
Extreme 5175.5
5,470
1 month 5,162.5
Extreme 5162.5
5,789
Current year 5,075
Extreme 5075
5,933.5
1 year 4,716.2
Extreme 4716.2
5,933.5
3 years 3,307.2
Extreme 3307.2
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,330
Extreme 1330
6,439.9
Manager TitleAgeSince
Chief Executive Officer - 2023-09-21
President - -
President - -
Director TitleAgeSince
Director/Board Member 62 2022-08-04
Director/Board Member 78 2015-03-15
Chairman 86 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.07%+0.89%+9.29%+56.31% 6.66B
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.07%+3.48%+53.32%+49.85% 580B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%0.00%+21.28%+16.70% 330B
+0.44%+3.48%+25.65%+35.66% 281B
-0.85%-2.86%+22.54%+14.67% 280B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+60.01% 192B
-0.22%-2.76%+14.19%+60.09% 156B
Average +0.20%+0.85%+17.97%+46.48% 343.56B
Weighted average by Cap. -0.23%+1.03%+27.73%+70.51%

Financials

2026 2027 *
Net sales 146B 1.54B 1.33B 1.22B 1.15B 2.15B 2.18B 14.51B 5.64B 71.11B 5.77B 5.65B 246B 166B 1.74B 1.5B 1.39B 1.3B 2.44B 2.47B 16.43B 6.38B 80.51B 6.53B 6.39B 279B
Net income 25.13B 264M 228M 210M 197M 370M 375M 2.49B 968M 12.22B 991M 970M 42.35B 23.92B 252M 217M 200M 188M 352M 357M 2.37B 922M 11.63B 944M 924M 40.32B
Net Debt -28.13B -296M -256M -235M -221M -414M -420M -2.79B -1.08B -13.68B -1.11B -1.09B -47.41B -30.47B -320M -277M -255M -239M -448M -455M -3.02B -1.17B -14.82B -1.2B -1.18B -51.36B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
18,785
Date Price Change Volume
26-06-12 5,298.00 -0.07% 67,310
26-06-11 5,301.50 +0.04% 120,184
26-06-10 5,299.50 -1.05% 117,951
26-06-09 5,355.50 -0.02% 177,273
26-06-08 5,356.50 +2.00% 225,217
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,298.00INR
Average target price
5,956.45INR
Spread / Average Target
+12.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALKEM Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!